TheraRadar
Clinical-Stage Companies / Natureceuticals Sdn Bhd

Natureceuticals Sdn Bhd

Pre-Approval PRO BETA
🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 10/1/2025

6
Total Trials
5
Phase 3
2
Phase 2
3
Recruiting
94
Score

Pipeline by Phase

Phase 3
5
Phase 2
2
Phase 1
1

Therapeutic Focus

Fatigue Colon Cancer Fatigue Related to Cancer Treatment Diabetic Retinopathy Asthenia

Clinical Trials (6)

NCT07669519 Phase 3 RECRUITING

Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy

Started: 8/18/2025

NCT07669454 Phase 3 RECRUITING

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.

Started: 10/1/2025

NCT07669467 Phase 3 RECRUITING

Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer

Started: 10/1/2025

NCT07669506 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing Chemotherapy

Started: 6/17/2025

NCT04546607 Phase 2 COMPLETED

Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia

Started: 9/2/2017

NCT04552600 Phase 1 COMPLETED

Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.

Started: 9/1/2019

Drug Candidates

Nuvastatic Nuvastatic™ Nuvastatic 300 Nuvastatic ™
Activity Status: Slowing
Last Trial Started: 10/1/2025
Last Trial Ended: 6/15/2026
Trials (12 months): 0
Completed Trials: 3
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.